SLC6A1

Clinical trials for SLC6A1 explained in plain language.

Never miss a new study

Get alerted when new SLC6A1 trials appear

Sign up with your email to follow new studies for SLC6A1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

First gene therapy attempt for rare brain disorder begins

Disease control ENROLLING_BY_INVITATION

This study tests a new gene therapy for people with SLC6A1 neurodevelopmental disorder, a rare genetic condition that affects brain function. One participant will receive a single injection of a harmless virus carrying a working copy of the SLC6A1 gene into the spinal fluid. The …

Matched conditions: SLC6A1

Phase: PHASE1, PHASE2 • Sponsor: Emily de los Reyes • Aim: Disease control

Last updated May 26, 2026 11:09 UTC

SLC6A1

Get alerted when new SLC6A1 trials appear

First gene therapy attempt for rare brain disorder begins